Hearing Aids Current Events | Hearing Aids News | 11
|
| Page
11 of
28 |
543 Results |
|
|
|
Sort By:
Page Views | Date |
How HIV cripples immune cells
In order to be able to ward off disease pathogens, immune cells must be mobile and be able to establish contact with each other. The working group around Professor Dr. Oliver Fackler in the Virology Department of the Hygiene Institute of the Heidelberg University Hospital has discovered a mechanism in an animal model revealing how HIV, the AIDS... view more... (2009-09-17)
Researchers find lack of key molecule leads to deafness
Researchers have identified tiny molecules that may lead to big breakthroughs in the treatment of hearing loss and deafness. view more (2009-04-17)
Hearing loss from chemotherapy underestimated
By 14, Peter Johnson had survived brain cancer and a relapse of the disease in his shoulder. But it was treatment for the last tumor that would create his life's greatest challenges. view more (2005-12-12)
Scientists identify molecular cause for one form of deafness
Scientists exploring the physics of hearing have found an underlying molecular cause for one form of deafness, and a conceptual connection between deafness and the organization of liquid crystals, which are used in flat-panel displays. view more (2007-02-06)
New Approaches To HIV Treatment In Less-developed Countries (pp 404, 410)
Two Viewpoint articles in this week's issue of THE LANCET highlight how the use of highly-active antiretroviral therapy (HAART) for HIV-1 treatment - currently only widely available in industrialised countries - could become accessible in less-developed settings. Both articles suggest new strategies for implementing HAART using infrastructure... view more... (2001-08-01)
Expansion of monocyte subset could serve as a biomarker for HIV progressions
An increase in the CD163+/CD16+ monocyte subset could be a biomarker for the progression of HIV disease, according to researchers at Temple University. view more (2008-03-28)
Six months after start of treatment could be optimum time for making prognosis in patients with HIV/AIDS (p 679)
Issue 30 August 2003 Embargoed 0001 h (London time) 29 August 2003. An international study in this week's issue of THE LANCET suggests that prognosis for patients with HIV/AIDS might be more reliably determined six months after initiation of highly active antiretroviral therapy (HAART), rather than before the start of treatment. HAART became... view more... (2003-08-27)
Inner ear balance disorders common, associated with falls among older Americans
An estimated 35 percent of U.S. adults age 40 and older have vestibular dysfunction (inner ear balance disorders), and those who do may have a higher risk of falling. view more (2009-05-26)
Background noise suppression technology aids hard of hearing
A revolutionary mechanism to allow hard-of-hearing people to distinguish between foreground dialogue and background music or sound effects in television programmes has been developed by a team of engineers led by Professor Ahmet Kondoz from the University of Surrey. Called Diction (Digitally Improving the Clarity of Television Narrative), the... view more... (2000-08-11)
No-entry zones for AIDS virus
The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs. view more (2009-11-13)
Reduction In HIV-1 Incidence Among Rural Ugandans Gives Hope To Other African Countries (pp 3, 41, 78)
A study in this week's issue of THE LANCET highlights a reduction in both HIV-1 incidence (the number of new cases) and prevalence (the number of cases in the population) from the beginning to the end of the past decade among a rural Ugandan population. Authors of the study conclude that the results could offer hope for other sub-Saharan countries... view more... (2002-07-03)
Scientists discover reason behind ear canal in Chinese frog: Ultrasonic communication
A rare frog that lives in rushing streams and waterfalls of east-central China is able to make itself heard above the roar of flowing water by communicating ultrasonically. view more (2006-03-16)
Measuring the auditory dynamics of selective attention
Call it the cocktail party effect: how an individual can participate in a one-on-one conversation within a cluster of people, switch to another, pick up important comments while tuning out others, change topics and return to the first conversation. view more (2008-08-22)
Got ear plugs? You may want to sport them on the subway and other mass transit, researchers say
The U.S. mass transit system, the largest in the world, provides affordable and efficient transportation to more than 33 million riders each weekday. The system is generally considered one of the safest modes of travel. But recent public health studies have identified several sources of environmental hazards associated with mass transit, including... view more... (2009-06-19)
Highly active antiretroviral therapy of similar benefit for HIV-infected injection drug users
Contrary to the belief that HIV-infected injection drug users (IDUs) receive less benefit from highly active antiretroviral therapy (HAART), new research finds little difference in the survival rate between IDUs and non-IDUs after 4-5 years of receiving HAART. view more (2008-08-04)
IAVI statement on new analysis of STEP large-scale AIDS vaccine trial
The International AIDS Vaccine Initiative (IAVI) issued the following statement from its President and CEO, Dr. Seth Berkley, following the release of the first analysis of the entire study population from a late-stage AIDS vaccine trial, known as the STEP study. view more (2007-11-08)
Causes of global death and disease in the next 25 years
In 1993, the World Bank sponsored the 1990 Global Burden of Disease study carried out by researchers at Harvard University and the World Health Organization (WHO). This study provided the first comprehensive global estimates of death and illness by age, sex, and region. view more (2006-11-28)
"EuroVacc 02" HIV Vaccine trial begins
The European Vaccine Effort against HIV/AIDS, today announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005. These vaccines are based on HIV subtype C, which is prevalent in China, India and sub-Saharan... view more... (2005-02-16)
Health as a mathematical model
Strategic management in AIDS prevention and hospital funding Vienna (FWF) - Having developed into a severe financial problem in many countries, AIDS has long ceased to be a purely emotional issue. Financial resources are channelled into preventive measures and into the treatment of AIDS patients with the aim of achieving maximum efficiency at... view more... (2001-08-21)
Study finds strong demand for HIV meds after high-risk sex
People who do not have HIV but seek antiretroviral medications following high-risk sexual encounters are very likely to complete the full monthlong drug regimen, according to a new UCLA AIDS Institute study. Moreover, there is a strong demand for publicly available post-exposure prophylaxis among high-risk populations in Los Angeles County. view more (2007-11-09)
|
|
| Page
11 of
28 |
543 Results |
|
|
|
Sort By:
Page Views | Date |
|
